MedTrace Logo

Late Metabolic Effects of Metformin Therapy in Gestational Diabetes

NCT02417090 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2020-12-11

No results posted yet for this study

Summary

Metformin in widely used as the treatment of gestational diabetes. However, it is not known whether exposure to metformin in utero has late metabolic effects on the child.

In this study the investigators investigate metabolism (oral glucose tolerance test, insulin, plasma lipoproteins, inflammation markers as well as body composition by DEXA (dual energy X-ray absorption) and MRI) in 9 year-old children whose mothers used either metformin of insulin during pregnancy.

Conditions

  • Gestational Diabetes

Interventions

DRUG

Insulin

Pregnant women who used insulin to treat gestational diabetes

DRUG

Metformin

Pregnant women who used metformin to treat gestational diabetes

Sponsors & Collaborators

  • Oulu University Hospital

    collaborator OTHER

  • Turku University Hospital

    lead OTHER_GOV

Principal Investigators

  • Harri J Niinikoski, MD, PhD · University of Turku

Eligibility

Min Age
9 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2019-12-01
Completion
2019-12-01

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02417090 on ClinicalTrials.gov